Related Experiment Video
Updated: Apr 20, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Influences of topical cyclopentolate on anterior chamber parameters with a dual-Scheimpflug analyzer in healthy
Insights
Topical cyclopentolate hydrochloride 1% significantly increased anterior chamber depth, volume, angle, and pupil size in children. Central corneal thickness remained unchanged. These findings impact biometric measurements and refractive surgery planning.
Area of Science:
- Ophthalmology
- Optometry
- Pediatric eye care
Background:
- Accurate anterior segment measurements are crucial for pediatric eye care.
- Cyclopentolate hydrochloride is commonly used for cycloplegia.
- The Galilei dual-Scheimpflug analyzer (GSA) provides detailed anterior segment imaging.
Purpose of the Study:
- To evaluate the effect of topical cyclopentolate hydrochloride 1% on anterior segment parameters in healthy children.
- To assess the utility of the Galilei dual-Scheimpflug analyzer (GSA) for these measurements.
Main Methods:
- Fifty healthy children (mean age 10.27 years) received three drops of cyclopentolate hydrochloride 1%.
- Anterior segment parameters (ACD, ACA, ACV, CCT, pupil size) were measured using the GSA before and 60 minutes after instillation.
- Paired t-tests were used for statistical analysis.
Main Results:
- A statistically significant increase was observed in anterior chamber depth (ACD), anterior chamber angle (ACA), anterior chamber volume (ACV), and pupil size (P < .05).
- Central corneal thickness (CCT) showed no significant change (P > .05).
Conclusions:
- Topical cyclopentolate hydrochloride 1% induces significant changes in multiple anterior segment parameters in children.
- These induced changes must be considered when performing biometric measurements and planning refractive surgery in pediatric populations.
- The GSA is effective in detecting these drug-induced changes.
Purpose:
To evaluate the changes of anterior segment parameters following the topical instillation of cyclopentolate hydrochloride 1% with the Galilei dual-Scheimpflug analyzer (GSA) (Ziemer Ophthalmology Co., Port, Switzerland) in healthy children.
Methods:
Fifty children (29 boys, 21 girls) were evaluated before and 60 minutes after instillation of three drops of 1% cyclopentolate hydrochloride using the GSA. The measurements before and after cycloplegia, including anterior chamber depth (ACD), anterior chamber angle (ACA), anterior chamber volume (ACV), central corneal thickness (CCT), and pupil size, were evaluated using the paired t test.
Results:
The mean age of the patients was 10.27 ± 3.32 years (range: 5 to 15 years). Measurements between the two sessions were significantly different for all parameters (P < .05), except for CCT (P > .05).
Conclusions:
The GSA demonstrated a statistically significant increase in ACD, ACV, ACA, and pupil size following the topical application of cyclopentolate hydrochloride 1%. These results should be considered during biometric measurement and refractive surgery planning.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Glaucoma: Overview
